Literature Reviews
doi: 10.25005/2074-0581-2019-21-2-291-297
SOFT TISSUE SARCOMA: A MODERN VIEW TO THE PROBLEM

V.V. Benberin1, B.T. Bayzakov2, N.A. Shanazarov1, S.V. Zinchenko3

1Medical center Hospital of President’s Affairs Administration of the Republic of Kazakhstan, Nur Sultan, Republic of Kazakhstan
2Medical Center of the West Kazakhstan Marat Ospanov Medical University, Aktobe, Republic of Kazakhstan
3Department of Surgery, Institute of Fundamental Medicine and Biology, Kazan (Volga region) Federal University, Kazan, Russian Federation

The review discusses the distribution and treatment of soft tissue sarcoma. Thus, about 10,000 new patients are registered in the Russian Federation every year; the incidence is 30 cases per 1 million populations. The age range of soft tissue sarcoma is on average 56-65 years with a peak in the age of 80-90 years. Fundamental aspects of the issue are illuminated. Thus, there are more than 100 histological types of soft tissue sarcoma; the most common include undifferentiated sarcomas, liposarcomas, leiosarcomas, synovial sarcomas and malignant tumor of peripheral nerve membranes. Considered issues of diagnostic criteria. According to the recommendations of the WHO to improve the accuracy of diagnosis in soft tissue sarcoma, the traditional histopathological examination should be supplemented with immunohistochemical and molecular methods. Studied modern approaches to the treatment of malignancies. One such approach is «Oncology Control», which means minimizing the risk of recurrence at the local and systemic level.

Keywords: Sarcoma, soft tissue sarcoma , diagnostic criteria of sarcoma, soft tissue sarcoma treatment standards, , soft tissue sarcoma classification.

Download file:

References
  1. Doyle LA. Sarcoma classification: an update based on the 2013 World Health Organization classification of tumors of soft tissue and bone. Cancer. 2014;120:1763-74.
  2. Cormier JN, Pollock RE. Soft tissues sarcomas. CA Cancer J Clin. 2004;54(2):94- 109.
  3. Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA) (FIBROSARC USA). Available from: https://clinicaltrials.gov/ct2/results?cond =Soft+tissue+sarcoma+&term=&cntry=&state=&city=&dist
  4. Fedenko AA, Gorbunova VA. Sarkomy myagkikh tkaney [Soft tissue sarcomas]. Moscow, RF: RONTS im. N.N. Blokhina RAMN; 2014. p. 23-34
  5. Siegel RL, Miller KD, Jemal A. Cancer statistics. Cancer J Clin. 2018;68(1):7-30. Available from: http://dx.doi.org/10.3322/caac.21442.
  6. Honoré C, Méeus P, Stoeckle E, Bonvalot SJ. Soft tissue sarcoma in France in 2015: Epidemiology, classification and organization of clinical care. Visc Surg. 2015;152(4):223-30. Available from: http://dx.doi.org/10.1016/j. jviscsurg.2015.05.001.
  7. Pollock RE, Karnell LH, Menck HR, Winchester DP. The National Cancer Data Base report on soft tissue sarcoma. Cancer. 2017;78(10):2247-57.
  8. Okada K, Hasegawa T, Kawai A, Ogose A, Nishida J, Yanagisawa M, et al. Primary (de novo) dedifferentiated liposarcoma in the extremities: a multiinstitution Tohoku Musculoskeletal Tumor Society study of 18 cases in northern Japan. Jpn J Clin Oncol. 2011;41:1094-100. Available from: http:// dx.doi.org/10.1093/jjco/hyr098.
  9. Sharma S, Kamala R, Nair D, Ragavendra TR, Mhatre S, Sabharwal R, et al. Round сell tumors: classification and immunohistochemistry. Indian J Med Paediatr Oncol. 2017;38(3):349-53. Available from: http://dx.doi. org/10.4103/ijmpo.ijmpo_84_16.
  10. Tsuda Y, Ogura K, Kobayashi E, Hiruma T, Iwata S, Asano N, et al. Impact of geriatric factors on surgical and prognostic outcomes in elderly patients with soft-tissue sarcoma. Jpn J Clin Oncol. 2017;47(5):422-9. Available from: http://dx.doi.org/10.1093/jjco/hyx016.
  11. Morhij R, Mahendra A, Jane M, McMillan D.C. The modified Glasgow prognostic score in patients undergoing surgery for bone and soft tissue sarcoma. J Plast Reconstr Aesthet Surg. 2017;70(5):618-24. Available from: http://dx.doi.org/10.1016/j.bjps.2017.01.016.
  12. Augsburger D, Nelson PJ, Kalinski T, Udelnow A, Knösel T, Hofstetter M, et al. Current diagnostics and treatment of fibrosarcoma – perspectives for future therapeutic targets and strategies. Oncotarget. 2017;10;8(61):104638-53. Available from: http://dx.doi.org/10.18632/oncotarget.20136.
  13. Fletcher CM, Bridge JA, Hogendoorn PW, Lyon MF. World Health Organization classification of tumours of soft tissue and bone. 4th ed. Lyon, France: IARC Press; 2013. p. 25-67.
  14. Jones DA, Shideman C, Yuan J, Dusenbery K, Carlos J, Ogilvie C, et al. Management of unplanned excision for soft-tissue sarcoma with preoperative radiotherapy followed by definitive resection. Am J Clin Oncol. 2016; 39(6):586-92. Available from: http://dx.doi.org/10.1097/ COC.0000000000000095
  15. Galy-Bernadoy C, Garrel R. Head and neck soft-tissue sarcoma in adults. Eur Ann Otorhinolaryngol Head Neck Dis. 2016;133(1):37-42. Available from: http://dx.doi.org/10.1016/j.anorl.2015.09.003.
  16. Tiwari A, Gupta VG, Bakhshi S. Newer medical therapies for metastatic soft tissue sarcoma. Expert Rev Anticancer Ther. 2017;17(3):257-70. Available from: http://dx.doi.org/10.1080/14737140.2017.1285229.
  17. Sápi Z. Pathology of soft tissue sarcoma. Onkol. 2014;58(1):11-23.
  18. Schöffski P, Cornillie J, Wozniak A, Li H, Hompes D. Soft tissue sarcoma: an update on systemic treatment options for patients with advanced disease. Oncol Res Treat. 2014;37(6):355-62. Available from: http://dx.doi. org/10.1159/000362631.
  19. Gerrand CH, Bell RS, Wunder JS, Kandel RA, O’Sullivan B, Catton CN, et al. The influence of anatomic location on outcome in patients with soft tissue sarcoma of the extremity. Cancer. 2015;97(2):485-92. Available from: http:// dx.doi.org/10.1245/ASO.2004.07.016.
  20. Kevin P. Boyd, MD, Bruce R. Korf, MD, Amy T. Neurofibromatosis type 1. J Am Acad Dermatol. 2014;61(1):1-16. Available from: http://dx.doi. org/10.1016/j.jaad.2008.12.051.
  21. Arnold J. Fraumeni syndrome monographs. Genes Cancer. 2011;2(4):475-84. Available from: http://dx.doi.org/10.1177/1947601911413466.
  22. Casali PG, Blay JY. Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(5):198-203. Available from: http://dx.doi.org/10.1093/annonc/mdq209.
  23. Patt JC, Haines N. Soft tissue sarcomas in skin: presentations and management. Semin Oncol. 2016;43(3):413-8. Available from: http://dx.doi. org/10.1053/j.seminoncol.2016.02.026.
  24. Ramu EM, Houdek MT, Isaac CE, Dickie CI, Ferguson PC, Wunder JS. Management of soft-tissue sarcomas: treatment strategies, staging, and outcomes. SICOT J. 2017;3:20. Available from: http://dx.doi.org/10.1051/ sicotj/2017010.
  25. Matsumoto S. Changes in the diagnosis and treatment of soft tissue sarcoma in Japan, 1977-2016. J Orthop Sci. 2018;23(3):441-8. Available from: http:// dx.doi.org/10.1016/j.jos.2017.11.0192700
  26. Wu JS, Hochman MG. Soft-tissue tumors and tumor like lesions: a systematic imaging approach. Radiology. 2009;253(2):297-316. Available from: http:// dx.doi.org/10.1148/radiol.2532081199.
  27. Amanda R, Karama A, Torsten O Nielsen. Advances in sarcoma diagnostics and treatment. Oncotarget. 2017:8(4):7068-93. Available from: http:// dx.doi.org/10.18632/oncotarget.12548
  28. Dangoor A, Seddon B, Gerrand C, Grimer R, Whelan J, Judson I. UK guidelines for the management of soft tissue sarcomas. Clin Sarcoma Res. 2016;15(6):20. Available from: http://dx.doi.org/10.1186/s13569-016-0060-4.
  29. Biau DJ, Ferguson PC, Turcotte RE, Chung P, Isler MH, Riad S, et al. Adverse effect of older age on the recurrence of soft tissue sarcoma of the extremities and trunk. J Clin Oncol. 2011;29(30):4029-35. Available from: http://dx.doi. org/10.1200/JCO.2010.34.0711.
  30. Domagoj Ante, Peter F. Soft-tissue sarcomas. Indian J Orthop. 2018;52(1):35- 44. Available from: http://dx.doi.org/10.4103/ortho.IJOrtho_220_17.
  31. Ingrid ME, Anastasia C, Suzanne EJ, Robin L, Winette TA. Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin. Cancer Manag Res. 2016;8:95-104. Available from: http://dx.doi.org/10.2147/ CMAR.S86746.
  32. Heidi B, Peter V, Mathias R, Akmal S, Johnny Keller. Routes to diagnosis for suspected sarcoma: the impact of symptoms and clinical findings on the diagnostic process. Sarcoma. 2016;32(2):45-70. Available from: http:// dx.doi.org/10.1155/2016/86392725.
  33. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics. CA Cancer J Clin. 2014;64(4):252-71. Available from: http://dx.doi.org/10.3322/caac.21235.
  34. Jared W, Kevin B, Jared J. Sarcoma – the standard-bearer in cancer discovery. Crit Rev Oncol Hematol. 2018;126:1-5. Available from: http://dx.doi. org/10.1016/j.critrevonc.2018.03.007.
  35. Mohamad F, Joanne N. Sarcomas associated with genetic cancer predisposition syndromes: a review. Oncologist. 2016;21(8):1002-13. Available from: http://dx.doi.org/10.1634/theoncologist.2016-0079.
  36. Verheijen P, Witjes H, van Gorp J, Hennipman A, van Dalen T. Current pathology work-up of extremity soft tissue sarcomas, evaluation of the validity of different techniques. Eur J Surg Oncol. 2010;36(1):95-9. Available from: http://dx.doi.org/10.1016/j.ejso.2009.05.004.
  37. Adams SC, Potter BK, Pitcher DJ, Temple HT. Office-based core needle biopsy of bone and soft tissue malignancies: an accurate alternative to open biopsy with infrequent complications. Clin Orthop Relat Res. 2010;468(10):2774-80. Available from: http://dx.doi.org/10.1007/s11999-010-1422-5.
  38. Khoja H, Griffin A, Dickson B, Wunder J, Ferguson P, Howarth D, et al. Sampling modality influences the predictive value of grading in adult soft tissue extremity sarcomas. Arch Pathol Lab Med. 2013;137(12):1774-9. Available from: http://dx.doi.org/10.5858/arpa.2012-0427-OA
  39. Maryam Ab, Sareh S, Mohammad K. Ewing sarcoma/primitive neuroectodermal tumor of the kidney. Int J Surg Case Rep. 2016;28:330-4. Available from: http://dx.doi.org/10.1016/j.ijscr.2016.10.014.
  40. Anant R, Bharat R, Sameer B, Sachin H, Manish A. Indian data on bone and soft tissue sarcomas: A summary of published study results. South Asian J Cancer. 2016;5(3):138-45. Available from: http://dx.doi.org/10.4103/2278- 330X.187587.
  41. Ratan R, Patel SR. Chemotherapy for soft tissue sarcoma. Cancer. 2016;122(19):2952-60. Available from: http://dx.doi.org/10.1002/ cncr.30191.593.
  42. Konecna J, Liberale G, Haddad J, de Saint-Aubain N, El Nakadi I. Diffuse intra-abdominal low grade fibromyxoid sarcoma with hepatic metastases: case report and review of the literature. Int J Surg Case Rep. 2015;14:40-3. Available from: http://dx.doi.org/10.1016/j.ijscr.2015.06.022.
  43. Laurini JA, Zhang L, Goldblum JR, Montgomery E, Folpe AL. Low-grade fibromyxoid sarcoma of the small intestine: report of 4 cases with molecular cytogenetic confirmation. Am J Surg Pathol. 2011;35(7):1069-73. Available from: http://dx.doi.org/10.1097/PAS.0b013e31821bc17a.
  44. Mastrangelo G, Coindre JM, Ducimetière F, Dei Tos AP, Fadda E, Blay JY, et al. Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions. Cancer. 2012;118(21):5339-48. Available from: http://dx.doi.org/10.1002/cncr.27555.
  45. Lin G, Doyle LA. An update on the application of newly described immunohistochemical markers in soft tissue pathology. Arch Pathol Lab Med. 2015;139(1):106-21. Available from: http://dx.doi.org/10.5858/arpa.2014- 0488-RA.
  46. Gino K, James S, William W. Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations. Ther Adv Med Oncol. 2017;9(8):533-50. Available from: http://dx.doi. org/10.1177/1758834017712963.
  47. Ravi V, Patel S, Benjamin RS. Chemotherapy for soft-tissue sarcomas. Oncology. 2015;29(1):43-50.
  48. Crago AM, Brennan F. Principles in management of soft tissue sarcoma. Adv Surg. 2015;49(1):107-22. Available from: http://dx.doi.org/10.1016/j. yasu.2015.04.002.
  49. Fedenko AA, Gorbunova VA. Sarkomy myagkikh tkaney [Soft tissue sarcomas]. Povolzhskiy onkologicheskiy vestnik. 2012;2:15-27.
  50. Riad S, Biau D, Holt GE, Werier J, Turcotte RE, Ferguson PC, et al. The clinical and functional outcome for patients with radiation-induced soft tissue sarcoma. Cancer. 2012;118(10):2682-92. Available from: http://dx.doi. org/10.1002/cncr.26543.
  51. Payne CE, Hofer SO, Zhong T, Griffin AC, Ferguson PC, Wunder JS. Functional outcome following upper limb soft tissue sarcoma resection with flap reconstruction. J Plast Reconstr Aesthet Surg. 2013;66(5):601-7. Available from: http://dx.doi.org/10.1016/j.bjps.2013.01.034.
  52. Dizon DS, Krilov L, Cohen E, Gangadhar T, Ganz PA, Hensing TA. Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. J Clin Oncol. 2016;34(9):987-1011. Available from: http://dx.doi.org/10.1200/JCO.2015.65.8427.
  53. Heymach J, Krilov L, Alberg A, Baxter N, Chang SM, Corcoran R. Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. J Clin Oncol. 2018;36(10):1020-44. Available from: http://dx.doi.org/10.1200/JCO.2017.77.0446.
  54. Townley WA, Mah E, O’Neill AC, Wunder JS, Ferguson PC, Zhong T. Reconstruction of sarcoma defects following pre-operative radiation: free tissue transfer is safe and reliable. J Plast Reconstr Aesthet Surg. 2013;66(11):1575-79. Available from: http://dx.doi.org/10.1016/j. bjps.2013.06.029.
  55. Abouarab MH, Salem IL, Degheidy MM, Henn D, Hirche C, Eweida A. Therapeutic options and postoperative wound complications after extremity soft tissue sarcoma resection and postoperative external beam radiotherapy. Int Wound J. 2018;15(1):148-58. Available from: http://dx.doi.org/10.1111/ iwj.12851.
  56. O’Donnell PW, Griffin AM, Eward WC, Sternheim A, Catton CN, Chung PW. The effect of the setting of a positive surgical margin in soft tissue sarcoma. Cancer. 2014;120(18):2866-75. Available from: http://dx.doi.org/10.1002/ cncr.28793.
  57. Ranieri G, Mammi M, Donato E. Pazopanib a tyrosine kinase inhibitor with strong anti-angiogenetic activity: a new treatment for metastatic soft tissue sarcoma. Crit Rev Oncol Hematol. 2014;89(2):322-39. Available from: http:// dx.doi.org/10.1016/j.critrevonc.2013.08.012.
  58. Jones KB, Ferguson PC, Deheshi B, Riad S, Griffin A, Bell RS. Complete femoral nerve resection with soft tissue sarcoma: functional outcomes. Ann Surg Oncol. 2010;17(2):401-6. Available from: http://dx.doi.org/10.1245/s10434- 009-0745-5.
  59. Bonvalot S, Rimareix F, Paumier A, Roberti E, Bouzaiene H, Le Péchoux C. What is new in the local approach of limb sarcomas and desmoid tumours? Cancer Radiother. 2010;14(7):455-9. Available from: http://dx.doi.org/10.1016/j. canrad.2010.06.016.
  60. Teplyakov VV, Karpenko VYu, Sedykh SA. Oshibki v diagnostike i lechenii sarkom myagkikh tkaney [Errors in the diagnosis and treatment of soft tissue sarcomas]. Khirurgiya. 2011;2(2):36-42.

Authors' information:

Benberin Valeriy Vasilievich
, Corresponding Member of the National Academy of Sciences of the Republic of Kazakhstan, Doctor of Medical Sciences, Full Professor, Director of the Medical center Hospital of President’s Affairs Administration of the Republic of Kazakhstan

Bayzakov Beybit Tlektesovich
, Head of Radiation Therapy Department, Medical Center of the West Kazakhstan Marat Ospanov Medical University

Shanazarov Nasrulla Abdullaevich
, Doctor of Medical Sciences, Full Professor, Deputy Director of Science and Strategy Development, Medical center Hospital of President’s Affairs Administration of the Republic of Kazakhstan

Zinchenko Sergey Viktorovich
, Doctor of Medical Sciences, Head of the Department of Surgery, Institute of Fundamental Medicine and Biology, Kazan (Volga region) Federal University

Conflicts of interest: No conflict

Address for correspondence:

Shanazarov Nasrulla Abdullaevich
Doctor of Medical Sciences, Full Professor, Deputy Director of Science and Strategy Development, Medical center Hospital of President’s Affairs Administration of the Republic of Kazakhstan

010000, Republic of Kazakhstan, Nur Sultan, E495 Str., 2

Tel.: +7 (717) 2708081

E-mail: nasrulla@inbox.ru

◄ Back to the list